EUVIMEDEUVIMED entdecken
Fallbericht

C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation

Shilpy Jha, Prit Benny Mulgulwar, Mehar Chand Sharma, Suvendu Purkait, Ashis Pattnaik, Mukund Namdev Sable

Neurology India · 2023

DOI: 10.4103/0028-3886.388099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neurology India, 2023. Verfasst von Shilpy Jha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: Supratentorial Neoplasms, Ependymoma. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipogenic differentiation in ependymoma is an infrequent occurrence with very few reported cases. The grading was done solely based on the histomorphology and molecular subtyping was not described in such ependymomas. New molecular classification divided ependymomas in nine different subgroups, of which supratentorial location tumor usually exhibits C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B fusion proteins. A 46-year-old female presented with headache and right-sided parapresis. Radilogy revealed a large intraxial left parietooccipital mass lesion, which histologically and immuohistochemically confirmed as anaplastic ependymoma with extensive lipogenic changes. The ependymal origin of the tumor was corroborated by the immunohistochemistry and ultrastructural studies. Molecular studies for C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B fusion proteins were negative. This is the first documentation of fusion negative supratentorial anaplastic ependymoma with lipogenic differentiation. This novel finding needs further reinforcement by similar studies to identify its impact on the disease outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supratentorial NeoplasmsEpendymomaFemaleHumansMiddle AgedTranscription Factor RelAImmunohistochemistryDNA-Binding ProteinsNuclear ProteinsTranscription FactorsProteins

Stichwörter der Autor:innen

Adipocytebrain tumorependymomamolecular subgroupsupratentorialultrastructure

Substanzen

Transcription Factor RelADNA-Binding ProteinsNuclear ProteinsTranscription FactorsProteinsRELA protein, humanMAMLD1 protein, humanZFTA protein, human

Autor:innen und Institutionen

  • Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
  • Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Pathology and Lab Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Neurosurgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.

Zitieren

APA

Jha, S., Mulgulwar, P. B., Sharma, M. C., Purkait, S., Pattnaik, A., & Sable, M. N. (2023). C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation. Neurology India. https://doi.org/10.4103/0028-3886.388099

Vancouver

Jha S, Mulgulwar PB, Sharma MC, Purkait S, Pattnaik A, Sable MN. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation. Neurology India. 2023. doi:10.4103/0028-3886.388099

BibTeX
@article{Jha2023,
  author = {Jha, Shilpy and Mulgulwar, Prit Benny and Sharma, Mehar Chand and Purkait, Suvendu and Pattnaik, Ashis and Sable, Mukund Namdev},
  title = {C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation},
  journal = {Neurology India},
  year = {2023},
  doi = {10.4103/0028-3886.388099}
}
Kostenlos starten →